Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Stomach Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasms 1Keratosis, Actinic 1Heart Failure 1Gastrointestinal Neoplasms 1Disease 1Colorectal Neoplasms 1Breast Neoplasms 1Biliary Tract Neoplasms 1Arrhythmias, Cardiac 1

Interventions

fluciclovine F-18 2Positron-Emission Tomography 2Injections 2Dexamethasone 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2tislelizumab 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1pembrolizumab 1lortalamine 1gossypol acetic acid 1daratumumab 1aflibercept 1Prednisone 1Oncolytic Virotherapy 1Octreotide 1Mitomycin 1Mammography 1Lenalidomide 1Ipilimumab 1Drug Delivery Systems 1Docetaxel 1Diagnosis, Computer-Assisted 1Daunorubicin 1Cytarabine 1Control Groups 1CPX-351 1Bevacizumab 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Disease × Control Groups × Clear all
NCT07335003 2026-01-12

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Cosmetique Active International

Phase NA Recruiting
80 enrolled
Dermatologic

Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡